Haidinger Michael, Geyeregger René, Poglitsch Marko, Weichhart Thomas, Zeyda Maximilian, Vodenik Barbara, Stulnig Thomas M, Böhmig Georg A, Hörl Walter H, Säemann Marcus D
Clinical Division of Nephrology and Dialysis, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
Transplantation. 2007 Jul 15;84(1):117-21. doi: 10.1097/01.tp.0000266677.45428.80.
Antithymocyte globulin (ATG) is employed for the treatment and prevention of acute organ rejection after transplantation. However, the mechanisms underlying its immunomodulatory capacities beyond cellular depletion remains ill defined. A stable interaction between T-cells and professional antigen-presenting cells (APC) and full T-cell stimulation requires a complex molecular rearrangement at the T-cell/APC interface, the so called immunological synapse. Here we investigated, whether ATG affects T-cell/APC interactions. ATG concentration and time-dependently inhibited relocalization of the T-cell receptor/CD3 complex as well as adhesion molecules and cytoskeletal proteins of human peripheral blood T-cells and a human T-cell line towards the APC contact site. Moreover, ATG-treated peripheral blood T-cells were incapable to form conjugates with APCs. In conclusion, ATG impairs T-cell/APC conjugate formation, a mechanism that may help to understand the functional inactivation of peripheral blood T-cells that have escaped cellular depletion after ATG treatment.
抗胸腺细胞球蛋白(ATG)用于治疗和预防移植后的急性器官排斥反应。然而,其除细胞清除作用外的免疫调节能力背后的机制仍不清楚。T细胞与专职抗原呈递细胞(APC)之间稳定的相互作用以及T细胞的充分刺激需要在T细胞/APC界面进行复杂的分子重排,即所谓的免疫突触。在此,我们研究了ATG是否会影响T细胞/APC的相互作用。ATG浓度和时间依赖性地抑制人外周血T细胞和人T细胞系的T细胞受体/CD3复合物以及粘附分子和细胞骨架蛋白向APC接触部位的重新定位。此外,经ATG处理的外周血T细胞无法与APC形成结合物。总之,ATG损害T细胞/APC结合物的形成,这一机制可能有助于理解ATG治疗后逃脱细胞清除的外周血T细胞的功能失活。